Daniel Kraft Speaking Topics

• Health and Medicine in the Age of AI: What’s Now, Near and Next

  A high-energy, highly visual signature keynote for healthcare, business, and investor audiences.

  What happens when healthcare becomes predictive, personalized, and connected? In his signature keynote, Dr. Daniel Kraft takes audiences on a fast-paced tour of accelerating technologies, from foundation models and agentic AI to wearables, multi-omics, robotics, and synthetic biology, and shows why the biggest shifts happen where they converge. His Now, Near and Next framework separates what is ready today from what is coming. Audiences leave inspired about what is possible and clear on what they can do about it, starting now.personalized, and connected.

• AI in Healthcare: From Pilots to Practice

  For clinical, health system, biopharma, payer, and healthcare technology audiences.

  Where is AI actually delivering value in healthcare, and where do the claims outrun the capability? Dr. Daniel Kraft offers a grounded look at generative, multimodal, and agentic AI across clinical documentation, decision support, diagnostics, patient engagement, and enterprise operations. He explains what separates real deployment from pilots that never scale: usable data, clinical validation, workflow integration, governance, and a payment model that works. Audiences leave knowing which applications to back first and how to prepare their teams.

• AI and the Future of Biopharma: From Discovery to the Patient

  For biopharma leadership, R&D, commercial, medical affairs, and market access teams.

  Dr. Daniel Kraft examines where AI is changing the economics of discovery and development, from target identification and molecular design to trial design, synthetic control arms, and regulatory submission. He treats the digitally enabled patient journey as one connected layer: shortening time to diagnosis, finding patients upstream, and understanding adherence and response. He also explores what changes for commercial, medical affairs, and market access teams. Leadership teams come away with a clear read on their own data position and the validation bar their AI claims should meet.

• Investing in the Future of Health: What’s Next and What Will Scale

  For investor groups, financial services firms, private equity, venture capital, and family offices. As a Kauffman Fellow and co-founder and general partner of Continuum Health Ventures, Daniel brings hands-on experience funding and advising companies from startup to public markets.

  Scientific progress creates possibilities; adoption decides which become durable businesses. Dr. Daniel Kraft, physician-scientist and general partner at Continuum Health Ventures, examines how AI, advanced diagnostics, longevity, and new models of care are rewriting business models across healthcare delivery, biopharma, and consumer health. Using his Now, Near and Next framework, he shows how reimbursement, workflow fit, and data advantage decide which companies actually get there. Investors leave with a sharper line between technical promise and commercial readiness.

• From Sick Care to Health Care: The Future of Longevity and Healthspan

  For consumer health, wellness, employer, payer, and longevity-focused audiences. A stem cell biologist trained in hematology, oncology and bone marrow transplantation, Daniel Kraft brings hands-on experience in regenerative medicine and clinical trials, and a clinician’s eye for separating longevity science from longevity marketing.

  How can we help people stay healthier for longer? Dr. Daniel Kraft, a physician and stem cell biologist, explores the shift from treating illness after it appears toward proactive, personalized health, with consumers reshaping prevention and monitoring without waiting for permission from the system. He examines what the evidence supports across metabolic health, sleep, and continuous monitoring, and what it does not. Audiences leave able to separate established practice from experimental approaches and commercial claims.

• Additional Speaking Topics

  Stage Zero: Earlier Detection and the Future of Prevention

  For diagnostics, laboratory, imaging, pathology, and life sciences audiences.

  What if we could detect disease at stage zero? Dr. Daniel Kraft explores how wearables, digital biomarkers, at-home testing, and low-cost personal omics reveal what happens between clinical visits, alongside liquid biopsy, multi-cancer early detection, computational pathology, and AI-assisted imaging. He examines what it means when the lab moves from the end of the workup to the front of prediction. Audiences leave with a practical test for any new diagnostic: does better detection lead to measurable patient benefit?

  From Hospital to Home: Care Without Walls

  For health systems, provider organizations, and care delivery audiences.

  As more care moves beyond the hospital and clinic, the challenge is redesigning how it is delivered. Dr. Daniel Kraft examines remote monitoring, digital health, home diagnostics, virtual care, and hospital-at-home, including the operational reasons promising programs stall before they scale. He explores the evolving clinician role, from the virtualist to AI-augmented teams, and what the hospital becomes as a result. Health system leaders leave with a clear view of what it takes to deliver more care safely at home.

  Leading Through Exponential Change

  A closed-door, facilitated strategy session for boards and executive leadership teams, drawing on Daniel Kraft’s role as founding faculty and chair of medicine at Singularity University and more than a decade leading Exponential Medicine, now NextMed Health.

  Dr. Daniel Kraft leads a facilitated, closed-door discussion of where AI, digital health, and emerging medicine touch an organization’s specific strategy, set against what competitors are actually doing. Applying exponential thinking and his Now, Near, Next and Needed framework, he helps leaders decide where to act, what to test, and what to monitor, starting with the data question. Available as a two-to-three-hour session or within a longer agreed agenda, with a written summary of agreed priorities.

Read More +